التفاصيل البيبلوغرافية
| العنوان: |
SGLT2 Inhibitor Therapy in Patients With Transthyretin Amyloid Cardiomyopathy. |
| المؤلفون: |
Porcari, Aldostefano, Cappelli, Francesco, Nitsche, Christian, Tomasoni, Daniela, Sinigiani, Giulio, Longhi, Simone, Bordignon, Luca, Masri, Ahmad, Serenelli, Matteo, Urey, Marcus, Musumeci, Beatrice, Cipriani, Alberto, Canepa, Marco, Badr-Eslam, Roza, Kronberger, Christina, Chimenti, Cristina, Zampieri, Mattia, Allegro, Valentina, Razvi, Yousuf, Patel, Rishi, Ioannou, Adam, Rauf, Muhammad U, Petrie, Aviva, Whelan, Carol, Emdin, Michele, Metra, Marco, Merlo, Marco, Sinagra, Gianfranco, Hawkins, Philip N, Solomon, Scott D, Gillmore, Julian D, Fontana, Marianna |
| المصدر: |
J Am Coll Cardiol ; ISSN:1558-3597 ; Volume:83 ; Issue:24 |
| بيانات النشر: |
Elsevier Science |
| سنة النشر: |
2024 |
| المجموعة: |
PubMed Central (PMC) |
| مصطلحات موضوعية: |
heart failure hospitalization, heart failure therapy, sodium-glucose cotransporter 2 inhibitors, survival, transthyretin amyloid cardiomyopathy |
| الوصف: |
Transthyretin cardiomyopathy (ATTR-CM) was an exclusion criterion in randomized clinical trials of sodium-glucose cotransporter 2 inhibitors (SGLT2i). |
| نوع الوثيقة: |
article in journal/newspaper |
| اللغة: |
English |
| العلاقة: |
https://doi.org/10.1016/j.jacc.2024.03.429Test; https://pubmed.ncbi.nlm.nih.gov/38866445Test |
| DOI: |
10.1016/j.jacc.2024.03.429 |
| الإتاحة: |
https://doi.org/10.1016/j.jacc.2024.03.429Test
https://pubmed.ncbi.nlm.nih.gov/38866445Test |
| حقوق: |
Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved. |
| رقم الانضمام: |
edsbas.A90695C6 |
| قاعدة البيانات: |
BASE |
